Efficient and Specific Internal Cleavage of a Retroviral Palindromic DNA Sequence by Tetrameric HIV-1 Integrase

Background HIV-1 integrase (IN) catalyses the retroviral integration process, removing two nucleotides from each long terminal repeat and inserting the processed viral DNA into the target DNA. It is widely assumed that the strand transfer step has no sequence specificity. However, recently, it has been reported by several groups that integration sites display a preference for palindromic sequences, suggesting that a symmetry in the target DNA may stabilise the tetrameric organisation of IN in the synaptic complex. Methodology/Principal Findings We assessed the ability of several palindrome-containing sequences to organise tetrameric IN and investigated the ability of IN to catalyse DNA cleavage at internal positions. Only one palindromic sequence was successfully cleaved by IN. Interestingly, this symmetrical sequence corresponded to the 2-LTR junction of retroviral DNA circles—a palindrome similar but not identical to the consensus sequence found at integration sites. This reaction depended strictly on the cognate retroviral sequence of IN and required a full-length wild-type IN. Furthermore, the oligomeric state of IN responsible for this cleavage differed from that involved in the 3′-processing reaction. Palindromic cleavage strictly required the tetrameric form, whereas 3′-processing was efficiently catalysed by a dimer. Conclusions/Significance Our findings suggest that the restriction-like cleavage of palindromic sequences may be a general physiological activity of retroviral INs and that IN tetramerisation is strongly favoured by DNA symmetry, either at the target site for the concerted integration or when the DNA contains the 2-LTR junction in the case of the palindromic internal cleavage.

[1]  E. Guiot,et al.  Relationship between the Oligomeric Status of HIV-1 Integrase on DNA and Enzymatic Activity* , 2006, Journal of Biological Chemistry.

[2]  Paul Shinn,et al.  Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection , 2006, PLoS pathogens.

[3]  E. Zubin,et al.  Probing of HIV-1 Integrase/DNA Interactions Using Novel Analogs of Viral DNA* , 2006, Journal of Biological Chemistry.

[4]  Robert Craigie,et al.  Retroviral DNA integration: reaction pathway and critical intermediates , 2006, The EMBO journal.

[5]  M. Gottikh,et al.  Kinetic study of the HIV−1 DNA 3′‐end processing , 2006, The FEBS journal.

[6]  D. Grandgenett,et al.  Recombinant Human Immunodeficiency Virus Type 1 Integrase Exhibits a Capacity for Full-Site Integration In Vitro That Is Comparable to That of Purified Preintegration Complexes from Virus-Infected Cells , 2005, Journal of Virology.

[7]  R. Craigie,et al.  Processing of Viral DNA Ends Channels the HIV-1 Integration Reaction to Concerted Integration , 2005, Journal of Biological Chemistry.

[8]  J. G. Levin,et al.  Effect of Polypurine Tract (PPT) Mutations on Human Immunodeficiency Virus Type 1 Replication: a Virus with a Completely Randomized PPT Retains Low Infectivity , 2005, Journal of Virology.

[9]  O. Delelis,et al.  A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles , 2005, Retrovirology.

[10]  D. Grandgenett Symmetrical recognition of cellular DNA target sequences during retroviral integration , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Burgess,et al.  Weak Palindromic Consensus Sequences Are a Common Feature Found at the Integration Target Sites of Many Retroviruses , 2005, Journal of Virology.

[12]  John M. Coffin,et al.  Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Castroviejo,et al.  HIV-1 integrase crosslinked oligomers are active in vitro , 2005, Nucleic acids research.

[14]  Mary K. Lewinski,et al.  Retroviral DNA integration--mechanism and consequences. , 2005, Advances in genetics.

[15]  D. Klatzmann,et al.  Early Detection of a Two-Long-Terminal-Repeat Junction Molecule in the Cytoplasm of Recombinant Murine Leukemia Virus-Infected Cells , 2004, Journal of Virology.

[16]  Y. Pommier,et al.  Azido-Containing Diketo Acid Derivatives Inhibit Human Immunodeficiency Virus Type 1 Integrase In Vivo and Influence the Frequency of Deletions at Two-Long-Terminal-Repeat-Circle Junctions , 2004, Journal of Virology.

[17]  Sophie Barbe,et al.  Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. , 2004, Molecular pharmacology.

[18]  M. Weitzman,et al.  Roles of host cell factors in circularization of retroviral dna. , 2003, Virology.

[19]  R. Harshey,et al.  Importance of the conserved CA dinucleotide at Mu termini. , 2001, Journal of molecular biology.

[20]  J. Mouscadet,et al.  HIV-1 integrase catalytic core: molecular dynamics and simulated fluorescence decays. , 2001, Biophysical journal.

[21]  Robert Craigie,et al.  HIV Integrase, a Brief Overview from Chemistry to Therapeutics* , 2001, The Journal of Biological Chemistry.

[22]  F. Bushman,et al.  Role of the non‐homologous DNA end joining pathway in the early steps of retroviral infection , 2001, The EMBO journal.

[23]  M. Sudoł,et al.  Nucleophile Selection for the Endonuclease Activities of Human, Ovine, and Avian Retroviral Integrases* , 2001, The Journal of Biological Chemistry.

[24]  P. Tauc,et al.  Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase. , 2000, Biochemistry.

[25]  J. Kypr,et al.  Invariant and Variable Base Stacking Geometries in B-DNA and A-DNA , 2000, Journal of biomolecular structure & dynamics.

[26]  M. Sudoł,et al.  Mapping target site selection for the non-specific nuclease activities of retroviral integrase. , 2000, Virus research.

[27]  D. Esposito,et al.  Sequence specificity of viral end DNA binding by HIV‐1 integrase reveals critical regions for protein–DNA interaction , 1998, The EMBO journal.

[28]  P. Brown,et al.  The Core Domain of HIV-1 Integrase Recognizes Key Features of Its DNA Substrates* , 1997, The Journal of Biological Chemistry.

[29]  M. Sudoł,et al.  Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases , 1996, Journal of virology.

[30]  M. Sudoł,et al.  Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases , 1995, Journal of virology.

[31]  H. Varmus,et al.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae , 1992, Journal of virology.

[32]  R. Plasterk,et al.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage , 1991, Journal of virology.

[33]  R. Swanstrom,et al.  Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants , 1990, Journal of virology.

[34]  P. Dehaseth,et al.  Circles with two tandem long terminal repeats are specifically cleaved by pol gene-associated endonuclease from avian sarcoma and leukosis viruses: nucleotide sequences required for site-specific cleavage , 1985, Journal of virology.

[35]  D. Grandgenett,et al.  Site-specific nicking at the avian retrovirus LTR circle junction by the viral pp32 DNA endonuclease. , 1985, Nucleic acids research.